U.S. Antimony (UAMY) grants RSUs and stock options to director Marinelli

Rhea-AI Filing Summary

United States Antimony Corp director Jon R. Marinelli reported receiving new equity awards under the company's Amended & Restated 2023 Equity Incentive Plan. On January 15, 2026, he was granted 1,659 shares of common stock underlying time-based restricted stock units (RSUs), with one-third, or 553 shares, scheduled to vest on January 15, 2027, and additional one-third tranches vesting on January 18, 2028 and January 16, 2029, subject to his continued service. He also received a stock option for 1,022 shares of common stock at an exercise price of $8.29 per share, vesting on the same three dates in equal installments of 341 shares, also conditioned on continued service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Marinelli Jon R

(Last) (First) (Middle)

4438 W. LOVERS LANE, UNIT 100

(Street)

DALLAS TX 75209

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITED STATES ANTIMONY CORP [ UAMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock(1)	$0.00	01/15/2026		A		1,659(1)		(1)	(1)	Common Stock	1,659	(1)	0(1)	D
Stock Option(2)	$8.29	01/15/2026		A		1,022(2)		(2)	(2)	Common Stock	1,022	(2)	0(2)	D

Explanation of Responses:

1. Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on January 15, 2026, under the Issuer's Amended & Restated 2023 Equity Incentive Plan. One-third, or 553 shares of the 1,659 total number of shares of the RSU award will vest on January 15, 2027, and an additional one-third of the total number of shares will vest on January 18, 2028 and January 16, 2029, subject to the Reporting Person's continued service through each vesting date.

2. Represents shares of Common Stock underlying a time-based vesting stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 341 shares of the 1,022 total number of shares on January 15, 2027, and an additional one-third of the total number of shares will vest on January 18, 2028 and January 16, 2029, subject to the Reporting Person's continued service through any vesting date.

	/s/ Jon R Marinelli	01/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did UAMY director Jon R. Marinelli report?

Jon R. Marinelli, a director of United States Antimony Corp (UAMY), reported the grant of 1,659 RSU-based shares of common stock and a stock option for 1,022 shares on January 15, 2026, under the company's Amended & Restated 2023 Equity Incentive Plan.

How many restricted stock units did UAMY grant to director Jon R. Marinelli and when do they vest?

United States Antimony granted Jon R. Marinelli 1,659 shares of common stock underlying time-based RSUs. One-third, or 553 shares, will vest on January 15, 2027, with additional one-third tranches vesting on January 18, 2028 and January 16, 2029, subject to his continued service through each vesting date.

What are the key terms of the stock options granted to UAMY director Jon R. Marinelli?

Jon R. Marinelli received a stock option covering 1,022 shares of UAMY common stock on January 15, 2026. The option has an exercise price of $8.29 per share and will vest in three equal installments of 341 shares on January 15, 2027, January 18, 2028, and January 16, 2029, contingent on his continued service.

Are the equity awards to UAMY director Jon R. Marinelli time-based or performance-based?

Both the 1,659-share RSU award and the 1,022-share stock option granted to Jon R. Marinelli are time-based vesting awards. Vesting on specified dates in 2027, 2028, and 2029 is conditioned on his continued service through each vesting date, with no additional performance conditions disclosed in the content.

Under which plan were Jon R. Marinelli's UAMY equity awards granted?

The RSU and stock option awards to Jon R. Marinelli were granted under United States Antimony Corp's Amended & Restated 2023 Equity Incentive Plan, as stated in the footnotes to the Form 4.

Does Jon R. Marinelli hold these UAMY awards directly or indirectly?

The Form 4 identifies Jon R. Marinelli's ownership of both the RSU-based common stock and the stock option as direct (D) ownership, with no indication in the footnotes that the awards are held through a separate entity.